Health Care & Life Sciences » Pharmaceuticals | Taisho Pharmaceutical Holdings Co. Ltd.

Taisho Pharmaceutical Holdings Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
51,316
40,162
35,809
41,956
48,070
64,484
Depreciation, Depletion & Amortization
12,387
12,938
12,473
11,670
11,380
11,290
Other Funds
311
284
288
284
895
48,016
Funds from Operations
54,236
35,985
39,776
39,180
44,391
27,758
Changes in Working Capital
5,997
2,271
3,282
886
4,539
8,536
Net Operating Cash Flow
60,233
33,714
43,058
40,066
39,852
19,222
Capital Expenditures
15,267
6,073
8,509
9,210
5,483
Sale of Fixed Assets & Businesses
234
1,330
33
39
868
Purchase/Sale of Investments
4,250
13,441
3,312
20,061
15,918
Net Investing Cash Flow
21,998
18,162
11,662
1,361
19,908
Cash Dividends Paid - Total
8,894
8,900
8,903
7,974
8,771
Issuance/Reduction of Debt, Net
124
162
236
45
103
Net Financing Cash Flow
9,439
9,443
19,525
8,404
9,867
Net Change in Cash
30,017
7,139
11,229
29,953
10,144
Free Cash Flow
50,413
28,450
36,135
32,744
37,126
Net Assets from Acquisitions
2,667
-
-
12,261
434
Other Sources
1
22
126
10
1,061
Change in Capital Stock
110
97
10,098
100
96
Exchange Rate Effect
1,221
1,030
642
348
67
Other Uses
49
-
-
-
-

About Taisho Pharmaceutical Holdings Co.

View Profile
Address
3-24-1 Takada
Tokyo Tokyo 170
Japan
Employees -
Website http://www.taisho-holdings.co.jp
Updated 07/08/2019
Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.